| 查看: 181 | 回复: 0 | |||
| 当前主题已经存档。 | |||
ronghui05铜虫 (小有名气)
|
[交流]
医学类，谢谢！
|
||
| Adenovirus-mediated gene therapy shows promise for cancer therapy, but transgene expression of replication-defective adenovirus may be low and transient in clinical settings. Recent reports have shown that the use of a conditionally replication-competent adenovirus (CRAd) enhanced the gene transduction of a replication-defective adenovirus vector. The control of tumor-stromal interactions has also been determined to be important in cancer therapy. In this study, we investigated the effect of the human telomerase reverse transcriptase (hTERT)-CRAd, Ad5/3hTERTE1, which possesses the tumor-specific hTERT promoter with the chimeric fiber 5/3, on the transgene expression and therapeutic efficacy of a replication-defective adenovirus vector expressing NK4 under the control of the CMV promoter, Ad-NK4. In addition, we established a new strategy to target both cancer cells and cancer-stromal interactions. Human pancreatic cancer cells were infected with Ad-NK4 and either Ad5/3hTERTE1 (CRAd-combination group) or Ad5/3hTERTLuc (control-combination group). In the CRAd-combination group, Ad-NK4-delivered transgene expression was increased, leading to an enhanced inhibitory effect on the invasion of cancer cells. In in vivo experiments, NK4 expression within tumors and its inhibitory effect on tumor growth, angiogenesis, and metastasis were enhanced in the CRAd-combination group. These results suggest that hTERT-CRAd enhances the transgene expression and therapeutic efficacies of Ad-NK4, possibly through the in-trans replication of Ad-NK4 induced by adenovirus E1 derived from co-infected hTERT-CRAd. This approach may be a promising combination therapy against advanced pancreatic cancer. |
回复此楼» 猜你喜欢
2026年WR青拔进展
已经有7人回复
-
职称论文投稿
已经有11人回复
-
中！中！中！
已经有10人回复
-
会评什么时候开始？
已经有4人回复
-
国自然申请五篇代表作大比拼，感觉这个是最重要的
已经有12人回复
-
无聊看看时间戳打发时间
已经有4人回复
-
咨询
已经有3人回复
-
基于自然哲学类比的风化壳型稀土矿
已经有14人回复
-
评委有多少概率知道其他专家手中有哪些人的本子？
已经有6人回复
-
求推荐期刊，重谢
已经有3人回复